ABCG2 and non-small cell lung carcinoma: For example, cabozantinib potentiated the cytotoxic properties of topotecan, mitoxantrone, and SN-38 in mitoxantrone-resistant NSCLC subline and several ABCG2-overexpressing cells [257].